The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment scenario . While the initial surge of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the loss of exclusivity in key markets has introduced considerable risk . Investors are now grappling with the effect of rival